HTML Preview Baby Immunization Schedule page number 1.
INDIAN PEDIATRICS 785 VOLUME 51
__
OCTOBER 15, 2014
Indian Academy of Pediatrics (IAP) Recommended Immunization
Schedule for Children Aged 0 through 18 years – India, 2014 and Updates
on Immunization
VIPIN M VASHISHTHA, PANNA CHOUDHURY, AJAY KALRA, ANURADHA BOSE, NAVEEN T HACKER, VIJAY N YEWALE,
CP BANSAL AND PRAVIN J MEHTA
Indian Academy of Pediatrics, Advisory Committee on Vaccines and Immunization Practices (ACVIP)
Correspondence to: Dr Vipin M Vashishtha, Convener, IAP Advisory Committee on Vaccines and Immunization Practices, Mangla
Hospital and Research Center, Shakti Chowk, Bijnor, Uttar Pradesh 246 701, India. [email protected]
T
he IAP Advisory Committee on Vaccines and
Immunization Practices (ACVIP) has recently
reviewed and revised the recommended
immunization schedule for children aged 0
through 18 years to ensure that the schedule reflects
recommendations based on recent evidences for licensed
vaccines in the country. The first annual meeting of the IAP
ACVIP was held on 19th and 20th April 2014 in New
Delhi. IAP ACVIP members and invited experts who
attended the meeting are listed in Annexure 1. The aim of
the meeting was to discuss and debate recent
developments in the field, to revise recommendations for
the IAP Immunization Timetable for the year 2014, and to
issue recommendations for available licensed vaccines in
the country. Following the meeting, a draft of revised
immunization schedule for the year 2014 was prepared
and circulated among the meeting participants to arrive at
a consensus.
The detailed process behind issuing IAP recommen-
dations on immunization – primarily for the pediatricians
in office practice has been described earlier [1]. These
recommendations provide guidelines to a pediatrician on
how best to utilize available licensed vaccines in their
office-practice settings. The members may use their own
discretion while using them in a given situation within the
framework suggested [2]. The existing National
immunization schedule and government policies are also
taken into account while drafting recommendations.
AIMS AND OBJECTIVES
To revise IAP Immunization Timetable for the year 2014,
and review and issue recommendations on the available
licensed vaccines.
RECOMMENDATIONS FOR IAP IMMUNIZATION
TIMETABLE, 2014
The IAP ACVIP has issued recommendations for the IAP
Immunization Timetable (Table I and Fig. 1) for the year
2014 that includes the following major changes from last
year:
G U I D E L I N E SG U I D E L I N E S
G U I D E L I N E SG U I D E L I N E S
G U I D E L I N E S
Justification: There is a need to review/revise recommendations
about existing vaccines in light of recent developments in the field
of vaccinology.
Process: Following an IAP ACVIP meeting on April 19 and 20,
2014, a draft of revised recommendations for the year 2014 and
updates on certain vaccine formulations was prepared and
circulated among the meeting participants to arrive at a
consensus.
Objectives: To review and revise recommendations for 2014
Immunization timetable for pediatricians in office practice and
issue statements on certain new and existing vaccine
formulations.
Recommendations: The major changes in the 2014
Immunization Timetable include two doses of MMR vaccine at 9
and 15 months of age, single dose recommendation for
administration of live attenuated H2 strain hepatitis A vaccine,
inclusion of two new situations in ‘high-risk category of children’ in
context with ‘pre-exposure prophylaxis’ of rabies, creation of a
new slot at 9-12 months of age for typhoid conjugate vaccine for
primary immunization, and recommendation of two doses of
human papilloma virus vaccines with a minimum interval of 6
months between doses for primary schedule of adolescent/
preadolescent girls aged 9-14 years. There would not be any
change to the committee’s last year’s (2013) recommendations
on pertussis vaccination and administration schedule of
monovalent human rotavirus vaccine. There is no need of
providing additional doses of whole-cell pertussis vaccine to
children who have earlier completed their primary schedule with
acellular pertussis vaccine-containing products. A brief update on
the new Indian Rotavirus vaccine, 116E is also provided. The
committee has reviewed and offered its recommendations on the
currently available pentavalent vaccine (DTwP+Hib+Hepatitis-B)
combinations in Indian market. The comments and footnotes for
several vaccines are also updated and revised.
Keywords: Immunity, Child, Guidelines, MMR Vaccine,
Vaccination.